What is the appropriate acute and ongoing management for severe angina pectoris?

Management of Severe Angina Pectoris

For acute severe angina lasting >1 minute, administer sublingual nitroglycerin immediately; if pain persists or worsens after 5 minutes, call 9-1-1 to activate emergency medical services—do not wait to take additional doses before seeking emergency care. 1, 2

Acute Management (Emergency Setting)

Immediate Actions for Severe/Unstable Angina

When severe angina occurs at rest, lasts >20 minutes, or represents a change in pattern (more frequent, severe, or precipitated by less effort):

• Activate EMS immediately - this is a medical emergency requiring hospital evaluation 2
• Aspirin 162-325 mg chewed (non-enteric coated for faster absorption) should be given by EMS or upon hospital arrival 1, 3
• Nitroglycerin sublingual or spray - one dose immediately, but do not delay calling 9-1-1 if symptoms persist beyond 5 minutes 1, 2
• Opiates for pain relief and anxiety reduction 4
• Oxygen if hypoxemic
• Continuous cardiac monitoring for arrhythmias

Hospital-Based Acute Treatment

Once in the emergency department with severe/unstable angina:

• Antiplatelet therapy: Aspirin plus a P2Y12 inhibitor (ticagrelor preferred over clopidogrel for early invasive strategy; prasugrel if undergoing PCI and not high bleeding risk) 1
• Anticoagulation: Unfractionated heparin, enoxaparin, fondaparinux, or bivalirudin 1
• Beta-blockers (unless contraindicated by bradycardia, hypotension, heart failure, or severe reactive airway disease) 1, 3
• Nitroglycerin IV infusion for ongoing ischemia 1
• Statins - high-intensity statin therapy initiated immediately 1
• Early invasive strategy (coronary angiography within 24-48 hours) is indicated for high-risk features: ongoing pain despite medical therapy, hemodynamic instability, arrhythmias, elevated troponins, or dynamic ECG changes 1

Ongoing Management (Chronic Stable Severe Angina)

First-Line Pharmacological Approach

The treatment hierarchy for symptomatic relief and prognostic benefit:

Step 1: Foundational Therapy (All patients require these)

1. Aspirin 81 mg daily (or clopidogrel 75 mg if aspirin contraindicated) - reduces MI and death 5, 3, 6

2. High-intensity statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) regardless of baseline LDL - reduces cardiovascular events and mortality 5, 3, 6

3. ACE inhibitor - particularly if prior MI, LV dysfunction (EF <40%), diabetes, or hypertension; reduces mortality 3, 6, 7

4. Beta-blocker - this is the preferred first-line antianginal agent because it provides both symptom relief AND reduces risk of HF hospitalization and death, especially post-MI 8, 5, 3, 6

   • Use bisoprolol, metoprolol succinate, or nebivolol (cardioselective)
   • Titrate to resting heart rate 55-60 bpm
   • Critical caveat: Beta-blockers are contraindicated in asthma but NOT in COPD 8

5. Sublingual nitroglycerin 0.4 mg - all patients must have this available for acute symptom relief 1, 5

Step 2: If Beta-Blocker Cannot Be Used

Alternatives when beta-blockers are contraindicated or not tolerated (choose one) 8, 5:

• Long-acting calcium channel blocker (amlodipine 5-10 mg daily or diltiazem extended-release) - Class IIa recommendation 8, 5
• Ivabradine (if in sinus rhythm) - reduces heart rate without negative inotropic effects 8
• Long-acting nitrates (isosorbide mononitrate with nitrate-free interval) 8, 5

Step 3: Add Second Antianginal if Symptoms Persist

When angina continues despite optimized first-line therapy, ADD (not substitute) 8, 9:

• Ivabradine - Class I recommendation when added to beta-blocker; safe in heart failure 8
• Long-acting calcium channel blocker (amlodipine) - can be combined with beta-blocker; Class I recommendation 8
• Long-acting nitrates - Class I recommendation but require nitrate-free interval (8-12 hours overnight) to prevent tolerance 8, 5
• Ranolazine 500-1000 mg twice daily - does not affect heart rate or blood pressure; particularly useful in diabetes 9, 10

Important combination caveat: Avoid combining non-dihydropyridine calcium channel blockers (diltiazem, verapamil) with beta-blockers due to excessive bradycardia and heart block risk. Dihydropyridines (amlodipine) can be safely combined with beta-blockers 10.

Blood Pressure Targets in Severe Angina

• Systolic BP 120-130 mmHg in general population
• Systolic BP 130-140 mmHg in patients >65 years old
• Use beta-blockers and/or calcium channel blockers as preferred agents since they treat both hypertension and angina 7

When Medical Therapy Fails

Coronary revascularization (PCI or CABG) is indicated when 5, 7:

• Angina persists despite optimal medical therapy (at least 2-3 antianginal drugs at maximum tolerated doses)
• Anatomically suitable lesions are present
• High-risk features: left main stenosis >50%, proximal three-vessel disease, proximal LAD stenosis with reduced LV function
• Severe symptoms significantly impair quality of life

CABG is preferred over PCI for:

• Left main disease
• Three-vessel disease, especially with diabetes or reduced LV function (EF <35%)
• Complex multivessel disease 5, 7

Refractory Angina (When All Else Fails)

For patients who remain severely symptomatic despite maximal medical therapy and are not candidates for revascularization 5, 11:

• Enhanced external counterpulsation (EECP) - 35 one-hour sessions over 7 weeks; improves angina class in 86% of patients 11
• Coronary sinus reducer - emerging interventional option 12
• Spinal cord stimulation - may be considered
• Ensure optimization of all three antianginal drugs at maximum tolerated doses before declaring refractory status

Critical Pitfalls to Avoid

1. Do not delay emergency care: The "wait and see" approach with multiple nitroglycerin doses before calling 9-1-1 increases mortality. The 5-minute rule is absolute 2.

2. Do not use short-acting dihydropyridine calcium channel blockers (immediate-release nifedipine) - they increase adverse cardiac events 6.

3. Do not combine ACE inhibitors with ARBs - increases harm without benefit 7.

4. Do not forget nitrate-free intervals - continuous nitrate exposure causes tolerance; ensure 8-12 hour nitrate-free period daily 5.

5. Do not assume all chest pain is cardiac - in primary care, musculoskeletal pain is most common (>50% of cases), but severe/prolonged pain must be treated as cardiac until proven otherwise 4.

6. Do not withhold beta-blockers in COPD - they are safe with cardioselective agents; only asthma is an absolute contraindication 8.

7. Do not forget risk factor modification - smoking cessation, Mediterranean diet, regular exercise, and weight management are as important as medications 7, 12.

Special Populations

Heart failure with reduced ejection fraction: Beta-blockers remain first-line; avoid non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to negative inotropic effects. Amlodipine is safe 8.

Diabetes: Tight glucose control is essential. CABG with internal mammary artery grafts is preferred over PCI for multivessel disease. Ranolazine may be particularly beneficial 3, 9.

Elderly (>65 years): Same medications are effective; adjust BP targets to 130-140 mmHg systolic. Higher risk of drug interactions and polypharmacy issues but same benefit from revascularization 5.

Post-CABG patients: Low threshold for angiography if recurrent symptoms due to multiple potential anatomic causes of ischemia 3.